GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BrightPath Biotherapeutics Co Ltd (TSE:4594) » Definitions » YoY Rev. per Sh. Growth

BrightPath Biotherapeutics Co (TSE:4594) YoY Rev. per Sh. Growth : -100.00% (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is BrightPath Biotherapeutics Co YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. BrightPath Biotherapeutics Co's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2023 was -100.00%.

BrightPath Biotherapeutics Co's Revenue per Share for the three months ended in Dec. 2023 was 円0.00.


BrightPath Biotherapeutics Co YoY Rev. per Sh. Growth Historical Data

The historical data trend for BrightPath Biotherapeutics Co's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BrightPath Biotherapeutics Co YoY Rev. per Sh. Growth Chart

BrightPath Biotherapeutics Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only -59.90 -92.76 -80.30 458.49 -69.93

BrightPath Biotherapeutics Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7,900.00 -99.63 -100.00 -100.00 -100.00

BrightPath Biotherapeutics Co YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

BrightPath Biotherapeutics Co's YoY Rev. per Sh. Growth for the fiscal year that ended in Mar. 2023 is calculated as:

YoY Rev. per Sh. Growth (A: Mar. 2023 )
=(Revenue per Share (A: Mar. 2023 )-Revenue per Share (A: Mar. 2022 ))/ | Revenue per Share (A: Mar. 2022 ) |
=(0.089-0.296)/ | 0.296 |
=-69.93 %

BrightPath Biotherapeutics Co's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY Rev. per Sh. Growth (Q: Dec. 2023 )
=(Revenue per Share (Q: Dec. 2023 )-Revenue per Share (Q: Dec. 2022 )) / | Revenue per Share (Q: Dec. 2022 )) |
=(0-0.08)/ | 0.08 |
=-100.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BrightPath Biotherapeutics Co YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of BrightPath Biotherapeutics Co's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


BrightPath Biotherapeutics Co (TSE:4594) Business Description

Traded in Other Exchanges
N/A
Address
2-2-4 Kojimachi, Kojimachi Central Building 7th Floor, Chiyoda-ku, Tokyo, JPN
BrightPath Biotherapeutics Co Ltd is a biopharmaceutical venture company. It is engaged in developing novel cancer immunotherapeutics. Its products include two candidate products: ITK-1 and GRN-1201 which are in the clinical trial stage.

BrightPath Biotherapeutics Co (TSE:4594) Headlines

No Headlines